Published in Neurology on February 23, 2010
Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis (2013) 1.15
Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy. Neuroophthalmology (2011) 0.95
In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Exp Neurol (2011) 0.92
A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study. Neuromuscul Disord (2015) 0.85
Therapeutic prospects for spinocerebellar ataxia type 2 and 3. Drugs Future (2009) 0.82
A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan. Orphanet J Rare Dis (2014) 0.80
Coenzyme Q10 and spinocerebellar ataxias. Mov Disord (2014) 0.79
Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. PLoS One (2014) 0.76
Degenerative Ataxias: challenges in clinical research. Ann Clin Transl Neurol (2016) 0.75
Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study. Chin Med J (Engl) (2015) 0.75
Ayurvedic approach in the management of spinocerebellar ataxia-2. Anc Sci Life (2016) 0.75
Quantitative evaluation of human cerebellum-dependent motor learning through prism adaptation of hand-reaching movement. PLoS One (2015) 0.75
A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias: a pilot open-labeled study. Neurol Sci (2016) 0.75
Inter-rater reliability and validity of two ataxia rating scales in children with brain tumours. Childs Nerv Syst (2015) 0.75
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet (1993) 5.82
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41
Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat Genet (1993) 3.04
Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (1999) 2.93
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A. J Chromatogr (1972) 2.87
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
Genetic analysis of IDDM: the GAW5 multiplex family dataset. Genet Epidemiol (1989) 2.73
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: application to mite sensitization. Am J Hum Genet (2000) 2.70
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer (2002) 2.53
Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch (2004) 2.44
Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology (2009) 2.33
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet (1994) 2.31
Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (2001) 2.17
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 2.09
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Transcellular ion flow in Escherichia coli B and electrical sizing of bacterias. Biophys J (1973) 2.06
Multiple ionization of atom clusters by intense soft X-rays from a free-electron laser. Nature (2002) 2.06
MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer (1997) 2.04
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02
MRI atlas of the human cerebellar nuclei. Neuroimage (2002) 2.00
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Prevalence of antigliadin antibodies in ataxia patients. Neurology (2003) 1.89
Cell lysis by induction of cloned lambda lysis genes. Mol Gen Genet (1981) 1.88
The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum Mol Genet (1997) 1.77
Adaptation to visuomotor rotation and force field perturbation is correlated to different brain areas in patients with cerebellar degeneration. J Neurophysiol (2009) 1.75
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg (2000) 1.72
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry (1999) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol (2001) 1.67
Localization of a cerebellar timing process using PET. Neurology (1995) 1.62
Quality of life following radical surgical treatment of gastric carcinoma. World J Surg (1999) 1.61
Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology (1990) 1.60
Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program. Am J Med Genet (1993) 1.59
Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry (1999) 1.59
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology (2011) 1.58
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Impairments of prehension kinematics and grasping forces in patients with cerebellar degeneration and the relationship to cerebellar atrophy. Clin Neurophysiol (2008) 1.56
Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56
Cryptotomography: reconstructing 3D Fourier intensities from randomly oriented single-shot diffraction patterns. Phys Rev Lett (2010) 1.55
Determinants of cord-blood IgE concentrations in 6401 German neonates. Allergy (1995) 1.55
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet (1995) 1.54
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology (2006) 1.54
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53